These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26463649)

  • 21. Hematopoietic Cell Transplantation after Solid Organ Transplantation.
    Doney KC; Mielcarek M; Stewart FM; Appelbaum FR
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2123-2128. PubMed ID: 26271193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies.
    Naik S; Martinez C; Leung K; Sasa G; Nguyen NY; Wu MF; Gottschalk S; Brenner M; Heslop H; Krance R
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1266-72. PubMed ID: 25765555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.
    Caimi PF; William BM; Silva Rondon CH; Fu P; Cooper BW; Campagnaro EL; Gerson SL; Reese-Koc J; Fox R; Creger RJ; de Lima M; Lazarus HM
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1926-31. PubMed ID: 26087475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is reduced-intensity conditioning the standard of care in the transplant setting?
    Giralt SA
    Clin Adv Hematol Oncol; 2008 May; 6(5):337-9. PubMed ID: 18516022
    [No Abstract]   [Full Text] [Related]  

  • 26. Mycophenolate-based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative-related donor stem cell transplantation.
    Hamad N; Shanavas M; Michelis FV; Uhm J; Gupta V; Seftel M; Kuruvilla J; Lipton JH; Messner HA; Kim DD
    Am J Hematol; 2015 May; 90(5):392-9. PubMed ID: 25615933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of transplantation with reduced and myeloablative conditioning for children with acute lymphoblastic leukemia.
    Kato K; Kato M; Hasegawa D; Kawasaki H; Ishida H; Okamoto Y; Koh K; Inoue M; Inagaki J; Kato K; Sakamaki H; Yabe H; Kawa K; Suzuki R; Atsuta Y
    Blood; 2015 Feb; 125(8):1352-4. PubMed ID: 25700427
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of in vivo T-cell depletion on reduced-intensity conditioning allogeneic stem cell transplantation from HLA-identical siblings in patients with follicular lymphoma.
    Delgado J; Canals C; Attal M; Thomson K; Campos A; Martino R; Littlewood T; Jackson G; Milpied N; Boogaerts M; Hunter A; Janssen JJ; Montoto S; Sureda A;
    Leukemia; 2011 Mar; 25(3):551-5. PubMed ID: 21183951
    [No Abstract]   [Full Text] [Related]  

  • 29. Nonmyeloablative conditioning for relapsed follicular lymphoma.
    van Besien K; Hari P
    Blood; 2008 Sep; 112(6):2585-6; author reply 2586-7. PubMed ID: 18779408
    [No Abstract]   [Full Text] [Related]  

  • 30. Feasible outcomes of T cell-replete haploidentical stem cell transplantation with reduced-intensity conditioning in patients with myelodysplastic syndrome.
    Shin SH; Kim JH; Jeon YW; Yoon JH; Yahng SA; Lee SE; Choi YS; Kim DY; Lee JH; Lee S; Kim HJ; Min CK; Lee JW; Lee KH; Min WS; Kim YJ; Lee JH
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):342-9. PubMed ID: 25459640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collection of hematopoietic stem cells after previous radioimmunotherapy is feasible and does not impair engraftment after autologous stem cell transplantation in follicular lymphoma.
    Derenzini E; Stefoni V; Maglie R; Casadei B; Pellegrini C; Broccoli A; Stefani G; Fanti S; Motta MR; Narducci R; Argnani L; Zinzani PL
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1695-701. PubMed ID: 24055654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-haploidentical T cell-depleted allogeneic hematopoietic stem cell transplantation in children with Fanconi anemia.
    Zecca M; Strocchio L; Pagliara D; Comoli P; Bertaina A; Giorgiani G; Perotti C; Corbella F; Brescia L; Locatelli F
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):571-6. PubMed ID: 24462983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic hematopoietic cell transplantation from unrelated donors in multiple myeloma: study from the Italian Bone Marrow Donor Registry.
    Passera R; Pollichieni S; Brunello L; Patriarca F; Bonifazi F; Montefusco V; Falda M; Montanari M; Guidi S; Giaccone L; Mordini N; Carella AM; Bavaro P; Milone G; Benedetti F; Ciceri F; Scimè R; Benedetti E; Castagna L; Festuccia M; Rambaldi A; Bacigalupo A; Corradini P; Bosi A; Boccadoro M; Bandini G; Fanin R; Bruno B
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):940-8. PubMed ID: 23538113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensive therapies in follicular non-Hodgkin lymphomas.
    Hunault-Berger M; Ifrah N; Solal-Celigny P;
    Blood; 2002 Aug; 100(4):1141-52. PubMed ID: 12149190
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of graft source on unrelated donor hemopoietic stem cell transplantation in adults with acute myeloid leukemia after reduced-intensity or nonmyeloablative conditioning: a study from the Société Francaise de Greffe de Moelle et de Thérapie Cellulaire.
    Malard F; Milpied N; Blaise D; Chevallier P; Michallet M; Lioure B; Clément L; Hicheri Y; Cordonnier C; Huynh A; Yakoub-Agha I; Peffault de Latour R; Mohty M
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1059-67. PubMed ID: 25708220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
    Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results.
    Khouri IF; Saliba RM; Erwin WD; Samuels BI; Korbling M; Medeiros LJ; Valverde R; Alousi AM; Anderlini P; Bashir Q; Ciurea S; Gulbis AM; de Lima M; Hosing C; Kebriaei P; Popat UR; Fowler N; Neelapu SS; Samaniego F; Champlin RE; Macapinlac HA
    Blood; 2012 Jun; 119(26):6373-8. PubMed ID: 22586182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In stem cell transplantation, by limiting the morbidity of graft-versus-host disease tolerance to myeloablative conditioning is improved.
    Novitzky N; Thomas V; du Toit C; Mcdonald A
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):709-18. PubMed ID: 18489997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
    Radujkovic A; Guglielmi C; Bergantini S; Iacobelli S; van Biezen A; Milojkovic D; Gratwohl A; Schattenberg AV; Verdonck LF; Niederwieser DW; de Witte T; Kröger N; Olavarria E;
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1230-6. PubMed ID: 25797175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.